{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:48:02Z","timestamp":1790837282766,"version":"4.1.0"},"reference-count":58,"publisher":"American Society for Clinical Investigation","issue":"9","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"National Research Agency","doi-asserted-by":"crossref","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R37HD014939"],"award-info":[{"award-number":["R37HD014939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA060750"],"award-info":[{"award-number":["R01CA060750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,10]]},"abstract":"<jats:p>\n                    Activating mutations in fibroblast growth factor receptor 3 (FGFR3) and inactivating mutations in the natriuretic peptide receptor 2 (NPR2) guanylyl cyclase both result in decreased production of cyclic GMP in chondrocytes and severe short stature, causing achondroplasia (ACH) and acromesomelic dysplasia, type Maroteaux, respectively. Previously, we showed that an NPR2 agonist BMN-111 (vosoritide) increases bone growth in mice mimicking ACH (\n                    <jats:italic>\n                      Fgfr3\n                      <jats:sup>Y367C\/+<\/jats:sup>\n                    <\/jats:italic>\n                    ). Here, because FGFR3 signaling decreases NPR2 activity by dephosphorylating the NPR2 protein, we tested whether a phosphatase inhibitor (LB-100) could enhance BMN-111\u2013stimulated bone growth in ACH. Measurements of cGMP production in chondrocytes of living tibias, and of NPR2 phosphorylation in primary chondrocytes, showed that LB-100 counteracted FGF-induced dephosphorylation and inactivation of NPR2. In ex vivo experiments with\n                    <jats:italic>\n                      Fgfr3\n                      <jats:sup>Y367C\/+<\/jats:sup>\n                    <\/jats:italic>\n                    mice, the combination of BMN-111 and LB-100 increased bone length and cartilage area, restored chondrocyte terminal differentiation, and increased the proliferative growth plate area, more than BMN-111 alone. The combination treatment also reduced the abnormal elevation of MAP kinase activity in the growth plate of\n                    <jats:italic>\n                      Fgfr3\n                      <jats:sup>Y367C\/+<\/jats:sup>\n                    <\/jats:italic>\n                    mice and improved the skull base anomalies. Our results provide a proof of concept that a phosphatase inhibitor could be used together with an NPR2 agonist to enhance cGMP production as a therapy for ACH.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.141426","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T14:01:18Z","timestamp":1620568878000},"source":"Crossref","is-referenced-by-count":14,"title":["Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth"],"prefix":"10.1172","volume":"6","author":[{"given":"Leia C.","family":"Shuhaibar","sequence":"first","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Kaci","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."},{"name":"Inovarion, F-75005 Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.","family":"Egbert","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Horville","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Loisay","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Vigone","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy F.","family":"Uliasz","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-7344","authenticated-orcid":true,"given":"Emilie","family":"Dambroise","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Swingle","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-8571","authenticated-orcid":true,"given":"Richard E.","family":"Honkanen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Biosse","family":"Duplan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."},{"name":"Service de M\u00e9decine Bucco-Dentaire, H\u00f4pital Bretonneau, AP-HP, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurinda A.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Connecticut Health Center, Farmington Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Legeai-Mallet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Imagine Institute, Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, F\u201175015, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/371252a0"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90302-6"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.24479"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0496-390"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81069-7"},{"issue":"24","key":"B6","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6690"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.1.35"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.07.020"},{"key":"B10","article-title":"Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.09.002"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.176"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008334"},{"issue":"42","key":"B14","first-page":"1839","article-title":"Le nanisme acrom\u00e9som\u00e9lique","volume":"79","author":"Maroteaux","year":"1971","journal-title":"Presse Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1086\/422013"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-13-44","article-title":"Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux","volume":"13","author":"Khan","year":"2012","journal-title":"BMC Med Genet"},{"issue":"1","key":"B17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.a.36218","article-title":"Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene","volume":"164A","author":"Miura","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20511"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20611"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071389098"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407894101"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C500024200"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds432"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1038\/srep10554","article-title":"The Local CNP\/GC-B system in growth plate is responsible for physiological endochondral bone growth","volume":"5","author":"Nakao","year":"2015","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042180"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.09.021"},{"key":"B27","article-title":"Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor","volume":"4;6","author":"Shuhaibar","year":"2017","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/bi972303k"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.25.15533"},{"issue":"9","key":"B30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147832","article-title":"Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism","volume":"6","author":"Wagner","year":"2021","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm971"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.10.014"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813446"},{"issue":"10252","key":"B34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0140-6736(20)31541-5","article-title":"Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial","volume":"39","author":"Savarirayan","year":"2020","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-1143"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04425-z"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8735"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010139"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2299"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80889-3"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180508095242"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.154"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa074"},{"issue":"2","key":"B44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbadis.2008.11.010","article-title":"Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia","volume":"1792","author":"Pannier","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02618"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.03.006"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr514"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1179104"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv182"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115320","article-title":"Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength","volume":"135","author":"Robinson","year":"2020","journal-title":"Bone"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12890"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2020.12.014"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)42069-8"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301063"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2014.603"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2007.079"},{"key":"B57","first-page":"23","article-title":"Small-molecule inhibitors of ser\/thr protein phosphatases: specificity, use and common forms of abuse","volume":"365","author":"Swingle","year":"2007","journal-title":"Methods Mol Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1242\/dev.112219"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/141426\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:43:57Z","timestamp":1779151437000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/141426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5,10]]},"published-print":{"date-parts":[[2021,5,10]]}},"alternative-id":["10.1172\/jci.insight.141426"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.141426","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"article-number":"e141426"}}